13. Multiple sclerosis/Neuromyelitis optica Clinical trials / Disease details
Clinical trials : 3,342 / Drugs : 2,355 - (DrugBank : 406) / Drug target genes : 269 - Drug target pathways : 241
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT05102682 (ClinicalTrials.gov) | March 10, 2017 | 25/10/2021 | Robotics for Mobility Rehabilitation in MS | Rex Robot Assisted Rehabilitation Exercise to Enhance Balance, Mobility and Upper Limb Function in People With Multiple Sclerosis | Multiple Sclerosis;MS | Other: Balance exercise program using exoskeleton device | East Kent Hospitals University NHS Foundation Trust | NULL | Completed | 18 Years | 90 Years | All | 11 | Phase 1 | United Kingdom |